"Manufacturers need reliable protections to recoup their development costs on approved medications and to invest in future efforts, but patients need the other side of the patent deal as well: reliable limits on the monopoly so that patients get the reduced pricing and improved access that was part of the original bargain."
Framing: assertive ·
First seen: 2026-09-10 ·
Last seen: 2026-09-10 ·
Spread: 1 articles